PortfoliosLab logoPortfoliosLab logo
SPXC vs. XBI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SPXC vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPX Technologies, Inc. (SPXC) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SPXC achieves a 9.78% return, which is significantly lower than XBI's 20.69% return. Over the past 10 years, SPXC has outperformed XBI with an annualized return of 31.12%, while XBI has yielded a comparatively lower 9.00% annualized return.


SPXC

1D
10.20%
1M
-3.57%
6M
5.38%
YTD
9.78%
1Y
11.85%
3Y*
37.60%
5Y*
26.93%
10Y*
31.12%
ALL TIME*
12.93%

XBI

1D
-2.94%
1M
-8.38%
6M
17.96%
YTD
20.69%
1Y
71.86%
3Y*
21.10%
5Y*
3.69%
10Y*
9.00%
ALL TIME*
11.58%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$126.37M$132.55M$165.00M
$1.17B$1.34B$1.30B

SPXC vs. XBI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SPXC
SPX Technologies, Inc.
9.78%37.48%44.06%53.86%10.00%9.42%7.19%81.65%-10.77%32.34%
XBI
SPDR S&P Biotech ETF
20.69%35.89%1.01%7.60%-25.87%-20.45%48.33%32.56%-15.28%43.77%

Correlation

The correlation between SPXC and XBI is 0.31, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.31

Correlation (3Y)
Balances recent behavior with more history.

0.42

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.41

Correlation (10Y)
Provides a long-term view across more market conditions.

0.40

Correlation (All Time)
Calculated using the full available price history since Feb 6, 2006

0.43

The correlation between SPXC and XBI shifts across timeframes, from 0.31 (1 year) to 0.43 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SPXC vs. XBI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

SPXC
SPXC Risk / Return Rank: 6262
Overall Rank
SPXC Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
SPXC Sortino Ratio Rank: 5959
Sortino Ratio Rank
SPXC Omega Ratio Rank: 5757
Omega Ratio Rank
SPXC Calmar Ratio Rank: 6464
Calmar Ratio Rank
SPXC Martin Ratio Rank: 6565
Martin Ratio Rank

XBI
XBI Risk / Return Rank: 9494
Overall Rank
XBI Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
XBI Sortino Ratio Rank: 9393
Sortino Ratio Rank
XBI Omega Ratio Rank: 9090
Omega Ratio Rank
XBI Calmar Ratio Rank: 9797
Calmar Ratio Rank
XBI Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

SPXC vs. XBI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPX Technologies, Inc. (SPXC) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SPXCXBIDifference
Sharpe ratioReturn per unit of total volatility

-2.20

Sortino ratioReturn per unit of downside risk

-2.51

Omega ratioGain probability vs. loss probability

1.12

1.42

-0.30

Calmar ratioReturn relative to maximum drawdown

0.86

6.92

-6.06

Martin ratioReturn relative to average drawdown

2.09

19.52

-17.43

SPXC vs. XBI - Sharpe Ratio Comparison

The current SPXC Sharpe Ratio is 0.49, which is lower than the XBI Sharpe Ratio of 2.70. The chart below compares the historical Sharpe Ratios of SPXC and XBI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SPXC vs. XBI - Drawdown Comparison

The maximum SPXC drawdown since its inception was -81.12%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for SPXC and XBI.


Loading charts...

Drawdown Indicators


SPXCXBIDifference

Max Drawdown

Largest peak-to-trough decline

-81.12%

-63.89%

-17.23%

Max Drawdown (1Y)

Largest decline over 1 year

-23.85%

-10.51%

-13.34%

Max Drawdown (3Y)

Largest decline over 3 years

-33.54%

-32.99%

-0.55%

Max Drawdown (5Y)

Largest decline over 5 years

-38.32%

-54.00%

+15.68%

Max Drawdown (10Y)

Largest decline over 10 years

-50.26%

-63.89%

+13.63%

Current Drawdown

Current decline from peak

-10.87%

-14.95%

+4.08%

Average Drawdown

Average peak-to-trough decline

-28.95%

-20.87%

-8.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.81%

3.72%

+6.09%

Volatility

SPXC vs. XBI - Volatility Comparison

SPX Technologies, Inc. (SPXC) has a higher volatility of 18.30% compared to SPDR S&P Biotech ETF (XBI) at 8.27%. This indicates that SPXC's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SPXCXBIDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.30%

8.27%

+10.03%

Volatility (6M)

Calculated over the trailing 6-month period

33.68%

21.50%

+12.18%

Volatility (1Y)

Calculated over the trailing 1-year period

41.44%

26.97%

+14.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.17%

32.32%

+3.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.75%

31.93%

+5.82%

Dividends

SPXC vs. XBI - Dividend Comparison

SPXC has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.39%.


PositionTTM20252024202320222021202020192018201720162015
SPXC
SPX Technologies, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%386.22%
XBI
SPDR S&P Biotech ETF
0.39%0.37%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%

Frequently Asked Questions


SPXC and XBI have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SPXC has higher volatility (18.30%) compared to XBI (8.27%). In terms of maximum drawdown, SPXC dropped -81.12% vs XBI's -63.89%.

XBI currently has the higher Sharpe Ratio (2.70 vs 0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SPXC and XBI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer